-
[show abstract]
[hide abstract]
ABSTRACT: Eutrophication has become a serious environmental threat throughout the world. In particular, the presence of cyanobacteria toxins, especially microcystins (MCs), has become a severe problem. Inhibition of Microcystis growth in water resources is the most effective way to reduce MCs, but it is a long-term investment. In the present study, a microgel-Fe(Ⅲ) complex was developed for the fast removal of MC-LR. The microgel-Fe(Ⅲ) characteristics and the MC-LR removal dynamics in Milli-Q water and natural water were evaluated. The removal efficiency negatively correlated to the initial MC-LR concentration and pH value (2.0-11.5), but the kinetics was not significantly influenced. The presence of natural organic matter (NOM) in water slightly reduced MC-LR removal using microgel-Fe(Ⅲ). In addition, microgel-Fe(Ⅲ) removed 98.99% of MC-LR in 12 min, while for activated carbon, it took 15-24 h to reach equilibrium. Furthermore, methanol was found to regenerate the microgel-Fe(Ⅲ) after MC-LR removal for at least five regeneration cycles. Finally, the microgel-Fe(Ⅲ) material was made into a membrane so that MCs could be removed by filtration. Therefore, microgel-Fe(Ⅲ) is an effective technology and has a great potential in removing MC-LR from drinking water resources.
Water Research 11/2011; 46(5):1482-9. · 4.86 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Microcystins (MCs), a cyclic heptapeptide hepatotoxins, are mainly produced by the bloom-forming cyanobacerium Microcystis, which has become an environmental hazard worldwide. Long term consumption of MC-contaminated water may induce liver damage, liver cancer, and even human death. Therefore, in addition to removal of MCs in drinking water, novel strategies that prevent health damages are urgently needed. Sulforaphane (SFN), a natural-occurring isothiocyanate from cruciferous vegetables, has been reported to reduce and eliminate toxicities from xenobiotics and carcinogens. The purpose of the present study was to provide mechanistic insights into the SFN-induced antioxidative defense system against MC-LR-induced cytotoxicity. We performed cell viability assays, including MTS assay, colony formation assay and apoptotic cell sorting, to study MC-LR-induced cellular damage and the protective effects by SFN. The results showed that SFN protected MC-LR-induced damages at a nontoxic and physiological relevant dose in HepG2, BRL-3A and NIH 3T3 cells. The protection was Nrf2-mediated as evident by transactivation of Nrf2 and activation of its downstream genes, including NQO1 and HO-1, and elevated intracellular GSH level. Results of our studies indicate that pretreatment of cells with 10muM SFN for 12h significantly protected cells from MC-LR-induced damage. SFN-induced protective response was mediated through Nrf2 pathway.
Toxicology and Applied Pharmacology 09/2010; 247(2):129-37. · 4.45 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The antiinflammatory activity of the aqueous extract of Polygala japonica (AEPJ) was investigated in mice and rats to find the pharmacological basis for its ethnomedical use. The extract produced a significant inhibition of peritoneal and cutaneous vascular permeability induced by acetic acid and histamine, respectively and ear swelling induced by picryl chloride in mice at the dose of 25.0 mg/kg. Moreover, the extract markedly inhibited footpad edema induced by histamine in rats, and decreased prostaglandin E(2) (PGE(2)) content in carrageenan-induced air-pouch at doses of 12.5 and 6.25 mg/kg respectively.
Fitoterapia 10/2006; 77(6):411-5. · 1.85 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The antibacterial activities of NE-2001 were tested against 24 clinical isolates of Helicobacter pylori and compared with those of amoxicillin, clarithromycin, metronidazole, and furazolidone. The MIC(50) and MIC(90) of this synthetic compound on the isolates were 8 and 16 mug/ml, respectively. This action was highly selective against Helicobacter pylori; there was a >4-fold difference between the concentration of NE-2001 required to inhibit the growth of Helicobacter pylori and that required to inhibit the growth of common aerobic and anaerobic bacteria. Exposure of Helicobacter pylori (ATCC43504) to NE-2001 at the MIC (4 mug/ml), or at a greater concentration, resulted in an extensive loss of viability. The phenomenon was also observed at pH levels between 3.0 and 7.0. When two clinical Helicobacter pylori strains were successively cultured at subinhibitory concentrations of NE-2001, no significant changes in the bactericidal effects were found. The morphological alterations of Helicobacter pylori cells (ATCC43504), exposed to NE-2001 at various concentrations for 6 h, were observed using transmission electron microcopy. The bacterium displayed features such as swelling, vacuole-like structures in the cytoplasm, and cell destruction following exposure to NE-2001. The efficacy of NE-2001 was maintained when evaluated in eight clinical isolates resistant to metronidazole and five isolates resistant to both metronidazole and clarithromycin (MIC ranging between 4 and 16 mug/ml). The above-described results suggest that NE-2001 may have the potential to be developed as a candidate agent for the treatment of Helicobacter pylori infection.
Antimicrobial Agents and Chemotherapy 09/2005; 49(8):3468-73. · 4.84 Impact Factor
